Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating...

cafead

Administrator
Staff member
  • cafead   Jan 24, 2023 at 10:52: AM
via ADAS-Cog mean scores changed minimally over 1 year in patients with mild-to-moderate Alzheimer’s disease treated with open-label simufilam tablets.

article source